Inovio Pharmaceuticals
INO
INO
126 hedge funds and large institutions have $142M invested in Inovio Pharmaceuticals in 2018 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 40 increasing their positions, 37 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
17% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 18
21% less call options, than puts
Call options by funds: $479K | Put options by funds: $603K
Holders
126
Holding in Top 10
–
Calls
$479K
Puts
$603K
Top Buyers
| 1 | +$2.38M | |
| 2 | +$2.18M | |
| 3 | +$1.78M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$1.27M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$801K |
Top Sellers
| 1 | -$1.2M | |
| 2 | -$651K | |
| 3 | -$579K | |
| 4 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$477K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$398K |